Encapsulated Cell Therapy | Neurotech Pharmaceuticals, Inc. | Cumberland

Neurotech Pharmaceuticals delivers MacTel treatment solutions, MacTel clinical trials, and MacTel Implant Encapsulated Cell Therapy.

Overview

Neurotech Pharmaceuticals, Inc. is a private biotech company specializing in therapies for chronic eye diseases, headquartered in Cumberland, RI. The company develops Encapsulated Cell Therapy (ECT), a drug delivery platform aimed at slowing the progression of idiopathic Macular Telangiectasia type 2 in adults and other chronic eye conditions. Neurotech Pharmaceuticals also conducts clinical trials related to MacTel treatment solutions and offers MacTel Implant Encapsulated Cell Therapy.

Details

Category
Biotechnology Research
Headquarters
Cumberland, RI
Type
Privately Held
Followers
13,149
Locations
900 Highland Corporate Drive, Building 1, Suite 101 Building 1, Suite 101 Cumberland, RI 02864, US